Advertisement
Persons > All
France
Monaco
Central France
Eastern France
Northern France
Paris (region)
Southern France
Western France
Find below all kinds of persons from France & Monaco.Total search results: 2358 | Ordered by Position (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Person | Position | Organisation (Group) | Region |
---|---|---|---|
Siciliano, Nicholas (Invisible Sentinel 201902 CEO + Co-Founder) | Chief Executive Officer (CEO) | Mérieux (Group) | Pennsylvania (federal state) |
Sieler, Miguel (Neovacs 201310 CEO before Bayer France CEO at Bayer since 1975) | Chief Executive Officer (CEO) | Neovacs (Group) | Île-de-France (region) |
Sierkstra, Laurens (BAC BV 200910 CEO) | Chief Executive Officer (CEO) | Thermo Fisher (Group) | North Holland (province, NL) |
Silvente, Stéphane (Affichem 201508 CEO + Co-founder) | Chief Executive Officer (CEO) | Affichem (Group) | Occitanie (Occitania) (region) |
Sixt, Bernhard (Edinburgh Molecular Imaging 201811– CEO before ImmunID + Agendia + Amersham + Nycomed) | Chief Executive Officer (CEO) | Edinburgh Molecular Imaging Ltd. (EM Imaging, EMI) | Scotland |
Solomon, David Horn (Mithra Pharmaceuticals 202304– before Pharnext+ Silence Tx + Zealand Pharma + Bionor Pharma) | Chief Executive Officer (CEO) | Mithra Pharmaceuticals (Group) | Wallonia (region) |
Sordet, Nicolas (Afyren 202108 CEO + Co-Founder before Link Securities + BNP Paribas + Société Générale) | Chief Executive Officer (CEO) | Afyren (Group) | Auvergne-Rhône-Alpes (region) |
Soriot, Pascal (AstraZeneca 201210– CEO before Roche COO Pharma Div before Genentech CEO) | Chief Executive Officer (CEO) | AstraZeneca (Group) | East of England (region) |
Sottilini, Frédéric (Carthera 202306 CEO) | Chief Executive Officer (CEO) | Carthera (Group) | Auvergne-Rhône-Alpes (region) |
Souêtre, Eric (Careventures 201011– Managing Partner + Labco 200904 CEO + Founder) | Chief Executive Officer (CEO) | Labco (Group) | France (region/state unspecified) |
Soula, Gérard (Adocia 201201 CEO + co-founder also founder of Flamel Technologies) | Chief Executive Officer (CEO) | Adocia S.A. | Auvergne-Rhône-Alpes (region) |
Spaggiari, Stefano (Expert System 201505 CEO) | Chief Executive Officer (CEO) | Expert System (Group) | Illinois (federal state) |
Spagnol, Michel (Novasep 201306– CEO before Shasun + Rhodia) | Chief Executive Officer (CEO) | Novasep (Group) | Grand Est (Great East) (region) |
Speedie, Patrick (In-Part 202202 Co-CEO + Co-Founder) | Chief Executive Officer (CEO) | Inpart (Group) | Yorkshire and the Humber (region) |
Spencer, Ryan (Dynavax 202004 CEO) | Chief Executive Officer (CEO) | Dynavax (Group) | California (federal state) |
Spinelli, Silvano (BiovelocITA 201511– before EOS SpA 200606– CEO + co-founder + Novupharma) | Chief Executive Officer (CEO) | Clovis Oncology (Group) | Lombardia (Lombardy) |
Sprecher, Jeffrey C. (IntercontinentalExchange 201311 CEO) | Chief Executive Officer (CEO) | IntercontinentalExchange (ICE) (Group) | Georgia (state) |
Spurling, Darryl (GeneSystems 200809 CEO) | Chief Executive Officer (CEO) | Danaher (Group) | Bretagne (Britanny) (region) |
Squarer, Ron (ADC Therapeutics 202003– Board Chairman + Advisor before CEO of Array BioPharma + Hospira + Mayne Pharma) | Chief Executive Officer (CEO) | Pfizer (Group) | Colorado (federal state) |
Stafford, Brian (ChemSW Inc 201309 CEO) | Chief Executive Officer (CEO) | Dassault Systèmes (3DS) (Group) | California (federal state) |
Stampacchia, Otello (Omega Advisors 200412 CEO) | Chief Executive Officer (CEO) | Omega Advisors (Group) | United States (USA)_o |
Stauber, Jonathan (ImaBiotech 201206 CEO) | Chief Executive Officer (CEO) | ImaBiotech (Group) | Hauts-de-France (Upper France) (region) |
Stein, Peter (Norgine 201108 CEO + Owner) | Chief Executive Officer (CEO) | Norgine (Group) | North Holland (province, NL) |
Straubinger, Helmut J. (Tricares 201603–2024032 CEO formerly JenaValve 200709 CEO RETIRED 3/24) | Chief Executive Officer (CEO) | Tricares (Group) | Île-de-France (region) |
Strigård, Helena (NorthX Biologics 202307 CEO formerly Director General at SwedenBIO) | Chief Executive Officer (CEO) | NorthX Biologics Matfors AB | Sweden_o |
Stuart, Edward (HS Life Sciences 200901 CEO + founder before Neurimmune 200712 CEO before U3 Pharma AG before DeveloGen) | Chief Executive Officer (CEO) | HS LifeSciences (Group) | Zürich (region) |
Sturge, Simon (Kymab 201905– CEO before Merck (DE) + Boehringer + OctoPlus + Vernalis + Celltech) | Chief Executive Officer (CEO) | Sanofi (Group) [since May 2011] | East of England (region) |
Sun, Jian-Sheng (DNA Therapeutics 200704 CEO + Chairman) | Chief Executive Officer (CEO) | Onxeo (Group) | Île-de-France (region) |
Suzuki, Ryuji (Repertoire Genesis 202205 CEO + Chairman) | Chief Executive Officer (CEO) | Eurofins (Group) | Kinki (region) |
Syage, Jack (Syagen 201107 CEO + founder) | Chief Executive Officer (CEO) | Safran (Group) | California (federal state) |
Sørensen, Nikolaj (Orexo 201810 CEO joined 201110 as CCO before Pfizer AB + Boston Consulting Group) | Chief Executive Officer (CEO) | Orexo (Group) | Uppsala (region) |
Takacs, Laszlo (BioSystems International 200512 CEO) | Chief Executive Officer (CEO) | BioSystems International (Group) | France (region/state unspecified) |
Talbot, Jonathan (Mosanna Therapeutics 202207 CEO + Co-Founder) | Chief Executive Officer (CEO) | Mosanna Therapeutics AG | Northwestern Switzerland (region) |
Tambourin, Pierre (Genopole 1998– Chief Executive) | Chief Executive Officer (CEO) | Genopole (GIP Genopole) | Île-de-France (region) |
Tanda, Stephan B. (Aptar 202106 CEO before DSM 201508 Executive Board Member Life Sciences) | Chief Executive Officer (CEO) | Aptar (Group) | Illinois (federal state) |
Taub, Robert (Nyxoah 20009– CEO + Co-Founder formerly Omrix –200802– CEO) | Chief Executive Officer (CEO) | Nyxoah S.A. | Belgium_o |
Tauber, Erich (Themis Bioscience GmbH 201505 CEO) | Chief Executive Officer (CEO) | Merck (US) (MSD) (Group) | Wien (state) |
Tavazoie, Masoud (Rgenix 201810 CEO + Co-Founder) | Chief Executive Officer (CEO) | Inspirna Inc. | New York (federal state) |
Tchelingerian, John (Promethera 201509– CEO before Silver Ocean Ventures + Neurotech + Diatos) | Chief Executive Officer (CEO) | Promethera (Group) | Belgium_o |
Tellier, Jean-Christophe (UCB 201403– CEO-elect joined UCB 2011 before Ipsen + Macrogenics + Novartis) | Chief Executive Officer (CEO) | UCB (Group) | Brussels (region) |
Tempelaere, Vincent (Eveon 202301 CEO) | Chief Executive Officer (CEO) | Eveon SAS | France (region/state unspecified) |
Templier, Alexandre (Quinten 202209 CEO + Co-Founder of Quinten) | Chief Executive Officer (CEO) | Quinten (Group) | Île-de-France (region) |
Tenkanen, Tuomas (Mobidiag 201304– CEO before RnD Director of Diagnostics PCR at Finnzymes) | Chief Executive Officer (CEO) | Hologic (Group) | Uusimaa |
Teper, Daniel (Cytovia Therapeutics 202102 CEO + Co-Founder) | Chief Executive Officer (CEO) | Cytovia Therapeutics Inc. | Massachusetts (federal state) |
Termeer, Henri A. (Genzyme 1985–201106 CEO joined Genzyme 1983) | Chief Executive Officer (CEO) | Sanofi (Group) [since May 2011] | Massachusetts (federal state) |
Thaker, Sumi (Momentum Bioscience 2016– CEO before Thermo Fisher + bioMérieux) | Chief Executive Officer (CEO) | Momentum Bioscience Ltd. | Wales |
Tharaud, Cécile (INSERM 201403– CEO of Inserm Transfert Initiative before CEO of Inserm Transfert) | Chief Executive Officer (CEO) | France (govt) | Île-de-France (region) |
Theodosiou, Jason (Aureus Pharma 200612– CEO before COO before Elsevier MDL + Lion Bioscience) | Chief Executive Officer (CEO) | Reed Elsevier (Group) | Île-de-France (region) |
Theurillat, Jacques (Ares Life Sciences CEO before Serono) | Chief Executive Officer (CEO) | BERTARELLI Group (family of Ernesto Bertarelli) | Région Lémanique (region) |
Thiroloix, Stéphane (AlgoTherapeutix 202303 CEO + Founder formerly Mayoly Spindler + Eucomed + Smith & Nephew + Ipsen) | Chief Executive Officer (CEO) | AlgoTherapeutix SAS (AlgoTx) | Île-de-France (region) |
Tierny, Dominique (OCR (FR) 201901 CEO + Founder) | Chief Executive Officer (CEO) | OCR (Oncovet Clinical Research) (FR) | Hauts-de-France (Upper France) (region) |
Timmerman, Benedikt (Genticel 201304 CEO + Founder) | Chief Executive Officer (CEO) | Calliditas Therapeutics (Group) | Occitanie (Occitania) (region) |
Tirouflet, Jean-Pierre (Biosystems International 200810 CEO) | Chief Executive Officer (CEO) | BioSystems International (Group) | France (region/state unspecified) |
Tocqué, Bruno (ExonHit 200506 CEO) | Chief Executive Officer (CEO) | Eurobio Scientific (Group) | Île-de-France (region) |
Tokay, Alexandre (Vect-Horus 201506 CEO + Co-founder) | Chief Executive Officer (CEO) | Vect-Horus (FR) | Provence-Alpes-Côte d’Azur (region) |
Tolmachov, Andrey (Enamine 202203 CEO + Founder) | Chief Executive Officer (CEO) | Enamine Ltd. (UA) | Ukraine_o |
Toulemonde, Gilles (Inova Software 201809 CEO + Co-Founder) | Chief Executive Officer (CEO) | Inpart (Group) | Auvergne-Rhône-Alpes (region) |
Tousi, Susan (Delfi Diagnostics 202401– CEO before Illumina + Eastman Kodak + HP) | Chief Executive Officer (CEO) | Delfi Diagnostics Inc. | Maryland (federal state) |
Tramoy, Philippe (Seventure Partners 201504 Investment Director at Quadrivium 1 seed fund) | Chief Executive Officer (CEO) | BPCE (Group) | Île-de-France (region) |
Tripathi, Vineeta (Vitarka Therapeutics 2021– CEO + Founder before Boehringer Ingelheim + Ipsen Bioinnovation) | Chief Executive Officer (CEO) | Vitarka Therapeutics Ltd. | South East England (region) |
Tripodi, Federico A. (Cellectis 201609c– CEO of Calyxt before Monsanto) | Chief Executive Officer (CEO) | Cellectis (Group) | Minnesota (federal state) |
Triva, Stefania (Copan 201501 CEO + General Manager) | Chief Executive Officer (CEO) | Copan (Group) | Lombardia (Lombardy) |
Tuffet, Sophie (Imagene 201907 CEO) | Chief Executive Officer (CEO) | Imagene S.A. | Nouvelle-Acquitaine (New Acquitaine) (region) |
Tupin, Cyrille (Abionyx 201909– CEO before Deputy CEO + CFO of predecessor Cerenis Therapeutics) | Chief Executive Officer (CEO) | Abionyx (Group) | Occitanie (Occitania) (region) |
Turenne, G. Andre (Matchpoint Therapeutics 202210 CEO before Voyager Tx + Sanofi + Genzyme + Feinstein Kean Healthcare) | Chief Executive Officer (CEO) | Matchpoint Therapeutics Inc. | Massachusetts (federal state) |
Turner, Stephen (Steve) (Protea Biosciences 201002 CEO) | Chief Executive Officer (CEO) | Protea Biosciences (Group) | West Virginia (federal state) |
Ulmann, André (Advicenne 202102– CMO before interim CEO) | Chief Executive Officer (CEO) | Advicenne S.A. (Euronext Paris: ADVIC) | Occitanie (Occitania) (region) |
Ulrich, Peter G. (TargeGen 201006 CEO + Co-founder) | Chief Executive Officer (CEO) | Sanofi (Group) [since May 2011] | California (federal state) |
Usache, Vincent (Microphyt 201907 CEO) | Chief Executive Officer (CEO) | Microphyt S.A. | Occitanie (Occitania) (region) |
Vaeck, Mark (Complix 201005– CEO before co-founder + founding CEO of ActoGenix + before Ablynx CEO) | Chief Executive Officer (CEO) | Complix (Group) | Flanders (Flemish region) |
Vaillant, Renaud (Theravectys 201209 CEO + France Biotech 201508 Board Director) | Chief Executive Officer (CEO) | Theravectys S.A. | Île-de-France (region) |
Valle, Francois (Vaxon Biotech 201412 CEO + MabLife 2014 CEO before Genewave) | Chief Executive Officer (CEO) | Vaxon Biotech S.A. | Île-de-France (region) |
Van Acker, Bart (Quality by Design 202204 CEO + Founder) | Chief Executive Officer (CEO) | QbD Group (Quality by Design) (Group) | Flanders (Flemish region) |
Van Broekhoven, Annie (Q-Biologicals 201211 CEO) | Chief Executive Officer (CEO) | Eurofins (Group) | Flanders (Flemish region) |
van de Stolpe, Onno (Galapagos 1999–202203 CEO + Founder before IntroGene BV + Molecular Probes Europe BV RETIRED 4/22) | Chief Executive Officer (CEO) | Galapagos (Group) | Flanders (Flemish region) |
van Eikeren, Paul (Blue Reference 200805 CEO) | Chief Executive Officer (CEO) | Waters (Group) | Oregon (federal state) |
van Gorp, Ad (Cytura Therapeutics 201903– CEO + Co-Founder before Lead Pharma 201502 CEO + Co-founder) | Chief Executive Officer (CEO) | Cytura Therapeutics B.V. | North Brabant (province, NL) |
Van Nieuwenhove, Thierry (Mérieux 202303 CEO of ABL formerly Novasep 201401– President of Synthesis Business Unit) | Chief Executive Officer (CEO) | Mérieux (Group) | United States (USA)_o |
van Tetering, Rob (Florimond Desprez 201404 CEO of SESVanderHave) | Chief Executive Officer (CEO) | Florimond Desprez (Group) | Belgium_o |
van Tunen, Arjen (Keygene 200601 CEO) | Chief Executive Officer (CEO) | KeyGene N.V. | Gelderland (province) |
Vannineuse, Pierre (Alpha Blue Ocean 2017– CEO + Co-Founder) | Chief Executive Officer (CEO) | Alpha Blue Ocean (ABO) (GB) | United Kingdom (state/region unspecified) |
Veillet, Stanislas (Biophytis 200609– CEO + Co-founder) | Chief Executive Officer (CEO) | Biophytis (Group) | Île-de-France (region) |
Veraart, Manon (Quercis Pharma 202104– CBO before Compass Pathways + Boston Consulting + Goldman Sachs) | Chief Executive Officer (CEO) | Quercis Pharma (Group) | Central Switzerland (region) |
Verleysen, Katleen (miDiagnostics 202105– CEO formerly Pronota 201201– CEO before COO) | Chief Executive Officer (CEO) | miDiagnostics N.V. | Belgium_o |
Vert, Jean-Philippe (Bioptimus 202402 CEO + Co-Founder before Owkin + Google Brain) | Chief Executive Officer (CEO) | ||
Vidal, Julien (AZMed 202402 CEO + Co-Founder) | Chief Executive Officer (CEO) | AZmed SAS | Pays de la Loire (region) |
Viens, Patrice (Unicancer 201507 CEO of Institut Paloi-Calmettes) | Chief Executive Officer (CEO) | Unicancer (Group) | Provence-Alpes-Côte d’Azur (region) |
Villain-Guillot, Philippe (Nosopharm 201703 President) | Chief Executive Officer (CEO) | Nosopharm SAS | Auvergne-Rhône-Alpes (region) |
Villalgordo, José Manuel (Villapharma Research 201612 CEO) | Chief Executive Officer (CEO) | Eurofins (Group) | Spain_o |
Vitt, Daniel (Immunic 201701– CEO before 4SC 1997–201612 CSO + Co-Founder before Univ Würzburg) | Chief Executive Officer (CEO) | Immunic (Group) | Bayern (federal state) |
von Braunmühl, Benedikt (Rentschler 202309– CEO before HMNC Brain Health + Medicover AB + Qiagen + Chiron Vaccines) | Chief Executive Officer (CEO) | Rentschler (Group) | Baden-Württemberg (federal state) |
Vonderscher, Jacky (Enyo Pharma 201602 CEO) | Chief Executive Officer (CEO) | Enyo Pharma S.A. | Auvergne-Rhône-Alpes (region) |
Waksal, Harlan W. (Kadmon 202109 CEO) | Chief Executive Officer (CEO) | Sanofi (Group) [since May 2011] | New York (federal state) |
Walker, Jerry (Lab21 –200710– CEO) | Chief Executive Officer (CEO) | Novacyt (Group) | South East England (region) |
Walls, Matthew (EpiStem 200704 CEO) | Chief Executive Officer (CEO) | Genedrive (Group) | North West England (region) |
Walmsley, Emma (GSK 201704– CEO before CEO of GSK Consumer Healthcare division joined GSK 2010 from L’Oréal) | Chief Executive Officer (CEO) | GSK (Group) | United Kingdom (state/region unspecified) |
Walrafen, Pierre (Scipio Bioscience 201711 CEO) | Chief Executive Officer (CEO) | Scipio Bioscience SAS | Île-de-France (region) |
Wattin, Martin (Contur Software AB 201105 CEO) | Chief Executive Officer (CEO) | Dassault Systèmes (3DS) (Group) | Stockholm (region) |
Weir, Neil (Sitryx Therapeutics 201804– CEO before UCB SVP Discovery) | Chief Executive Officer (CEO) | Sitryx Therapeutics Ltd. | South East England (region) |
Weiss, Mario (GAIA 201702 CEO + Founder) | Chief Executive Officer (CEO) | GAIA AG | Hamburg (federal state) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top